PhD or MD in a relevant scientific field (e.g., Molecular Biology, Cell Biology, Oncology, Immunology, etc.).
Minimum of 5 years of pharmaceutical industry experience in Translational Medicine, Clinical Development, or Biology research, with a strong preference for candidates possessing a background in biomarker research or clinical biomarker development. Proven experience in E2E clinical drug development, including drafting relevant documents (e.g., protocols, ICFs) and a solid understanding of cross-functional interfaces such as Clinical Science, Clinical Pharmacology, Regulatory, Safety, Operations, and Biostatistics. Deep familiarity with the regulatory landscape and competitive environment in China. Extensive knowledge of state-of-the-art biomarker technologies, including immunoassays, NGS, IHC, FACS, PCR, and imaging-based modalities (MRI/DXA/PET). Demonstrated expertise in generating and interpreting data from diverse sample types to establish proof of biology, support dose selection, and develop patient enrichment strategies. Thrives in a dynamic, inclusive environment, taking full accountability for personal contributions and development. Resourceful and flexible problem-solver, capable of working collaboratively while ensuring cross-team alignment. Transparent and empathetic leader with strong coaching skills and a commitment to keeping teams informed and engaged. Strategic thinker with a holistic, ecosystem-oriented mindset, coupled with strong analytical abilities. Excellent communication and interpersonal skills in both English and Chinese, with the proven ability to influence stakeholders and drive consensus.